Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J. Earley

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Sleep Medicine|February 21, 2018
Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs SyndromeYong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine|August 20, 2016
Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentationChristopher J Earley, George R Uhl, Stefan Clemens, et al.
Sleep Medicine|January 18, 2011
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndromeNathan Silver, Richard P Allen, Julia Senerth, et al.
Sleep Medicine|February 6, 2016
Inter-movement interval as a primary stable measure of periodic limb movements of sleepPatrick Skeba, Kasidet Hiranniramol, Christopher J Earley, et al.
Sleep Medicine|December 3, 2014
Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)Tahir Mehmood, Michael Auerbach, Christopher J Earley, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|July 27, 2018
New Insights into the Neurobiology of Restless Legs SyndromeSergi Ferré, Diego García-Borreguero, Richard P Allen, et al.
Sleep|April 16, 2024
Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trialChristopher J Earley, Diego García-Borreguero, Mark Falone, et al.
Sleep Medicine|November 14, 2006
The effects of dietary iron deprivation on murine circadian sleep architectureTerry Dean, Richard P Allen, Christopher P O'Donnell, et al.
Sleep Medicine|January 10, 2021
Developing a biomarker for restless leg syndrome using genome wide DNA methylation dataArunima Roy, Christopher J Earley, Richard P Allen, et al.
Neurology|April 30, 2013
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleepRichard P Allen, Peter B Barker, Alena Horská, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Sleep Medicine|February 21, 2018
Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs SyndromeYong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine|August 20, 2016
Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentationChristopher J Earley, George R Uhl, Stefan Clemens, et al.
Sleep Medicine|January 18, 2011
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndromeNathan Silver, Richard P Allen, Julia Senerth, et al.
Sleep Medicine|February 6, 2016
Inter-movement interval as a primary stable measure of periodic limb movements of sleepPatrick Skeba, Kasidet Hiranniramol, Christopher J Earley, et al.
Sleep Medicine|December 3, 2014
Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)Tahir Mehmood, Michael Auerbach, Christopher J Earley, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|July 27, 2018
New Insights into the Neurobiology of Restless Legs SyndromeSergi Ferré, Diego García-Borreguero, Richard P Allen, et al.
Sleep|April 16, 2024
Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trialChristopher J Earley, Diego García-Borreguero, Mark Falone, et al.
Sleep Medicine|November 14, 2006
The effects of dietary iron deprivation on murine circadian sleep architectureTerry Dean, Richard P Allen, Christopher P O'Donnell, et al.
Sleep Medicine|January 10, 2021
Developing a biomarker for restless leg syndrome using genome wide DNA methylation dataArunima Roy, Christopher J Earley, Richard P Allen, et al.
Neurology|April 30, 2013
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleepRichard P Allen, Peter B Barker, Alena Horská, et al.
Pageof 15